Compare MTCH & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTCH | TECH |
|---|---|---|
| Founded | 1986 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 9.5B |
| IPO Year | 2015 | 1989 |
| Metric | MTCH | TECH |
|---|---|---|
| Price | $32.59 | $58.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 14 |
| Target Price | $35.00 | ★ $71.23 |
| AVG Volume (30 Days) | ★ 3.0M | 1.8M |
| Earning Date | 02-03-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.29% | 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.15 | 0.49 |
| Revenue | ★ $3,469,367,000.00 | $1,216,732,000.00 |
| Revenue This Year | $2.06 | $2.33 |
| Revenue Next Year | $3.46 | $7.05 |
| P/E Ratio | ★ $15.46 | $120.21 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $26.39 | $46.01 |
| 52 Week High | $39.20 | $79.28 |
| Indicator | MTCH | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 42.18 |
| Support Level | $33.35 | $58.75 |
| Resistance Level | $34.35 | $61.20 |
| Average True Range (ATR) | 0.75 | 2.01 |
| MACD | -0.05 | -0.54 |
| Stochastic Oscillator | 4.24 | 13.44 |
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.